// App-Quantinova.ai

TCT-353 : Long-Term Outcomes of Biodegradable Polymer Drug-Eluting Stents versus Durable Polymer Sirolimus-Eluting Stents in Patients with Diabetes: A Pooled Analysis of Individual Patient Data from the ISAR-TEST 4 and LEADERS Randomized Trials

Researchers

Presenter

  • Lamin King

Principal Investigators

  • Antoinette de Waha

  • lamin king

  • Robert Byrne

  • Salvatore Cassese

  • Adnan Kastrati

  • Stephan Windecker

Medical Centers

  • Deutsches Herzzentrum Munchen, Munich, Germany

  • IBCSG and University Hospital, Berne, Switzerland

  • Deutsches Herzzentrum Munchen, Munich, Germany

Locations

  • Germany

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Venous thrombosis

  • Restenosis

  • Diabetes

Biomarkers

  • N/A

Drug/Treatment

  • Rapacan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved